Riskpilot← Back to searchSign inGet full accessSafevitalis AB
ABDissolvedOrg 5567510440General medical practice activities · NACE 8621Est. 20080 employees
Revenue 2024
SEK 3,6M
-40% vs 2023
EBITDA margin
7.1%
-83% vs 2023
Equity ratio
20.6%
Financial strength
Net profit 2024
SEK 7K
-85% vs 2023
| Revenue | SEK 3,6M | -40% |
| EBITDA | SEK 259K | -83% |
| Net profit | SEK 7K | -85% |
| Total assets | SEK 8,3M | -18% |
| Equity | SEK 1,7M | -15% |
| Employees | 0 | — |
Legal name
Safevitalis AB
Org number
5567510440
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
31 januari 2008
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verkamhet är hälso och sjukvård, utbildningverksamhet samt tv och filmproduktion och därmed förenlig verksamhet.
Address
Email
dag.strom@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 492 | 3 199 | 3 887 | 6 076 | 3 645 |
| Staff expenses | — | — | −1 077 | −1 668 | −2 141 |
| EBITDA | 1 291 | 1 468 | 1 593 | 1 504 | 259 |
| Depreciation & amort. | −141 | −125 | −136 | −136 | −8 |
| EBIT | 1 150 | 1 343 | 1 457 | 1 368 | 251 |
| Net financials | 178 | 364 | −682 | −1 239 | −108 |
| Profit before tax | 967 | 1 249 | 502 | 441 | 274 |
| Tax | −219 | −230 | −263 | −393 | −267 |
| Net profit | 748 | 1 019 | 239 | 48 | 7 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 000 | 7 516 | 8 398 | 10 040 | 8 265 |
| Equity | 1 338 | 1 708 | 1 946 | 1 994 | 1 701 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 1 444 | 1 951 | 2 169 | 3 949 | 2 251 |
| Total debt | 1 444 | 1 951 | 2 169 | 3 949 | 2 251 |
EBITDA margin
7.1%
This company
15.8%
Market median
-55% vs market
20202024
Equity ratio
20.6%
This company
38.2%
Market median
-46% vs market
20202024
Return on equity
0.4%
This company
18.4%
Market median
-98% vs market
20202024
Net profit margin
0.2%
This company
8.1%
Market median
-98% vs market
20202024
Asset turnover
0.44×
This company
1.12×
Market median
-61% vs market
20202024
Debt / equity
3.86×
This company
0.62×
Market median
-523% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PD Chief Auditor | Chief Auditor | 2025 |
| Former (1) | ||
JÅ | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Safevitalis AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Åke Mikael Ejnarsson | Audit | 0 companies |
| Per David Algot Persson | Chief Auditor | 0 companies |
| Benjamin Karl Emil Ström | Deputy Board Member | 0 companies |
| Dag Owe Emanuel Ström | Board of Directors | 0 companies |